Patients' perceived helpfulness of certain actions by health care professionals was linked to earlier insulin initiation and greater insulin continuation over time, a survey found.
Patients with diabetes and obesity who had metabolic surgery were matched in a 1:5 ratio to those who received usual care, with incidence of a major cardiovascular event (MACE) as the primary outcome.
The comparison of dipeptidyl peptidase-4 inhibitors with other drug classes did find higher rates of major adverse cardiovascular events with basal insulin, sulfonylureas, and meglitinides than with the newer drugs.
The American Heart Association (AHA) addressed use of antithrombotics, hypertension drugs, and cholesterol therapies in patients with stable coronary artery disease and diabetes, among other recommendations.
In a retrospective observational study, patients with prediabetes were assigned to a risk category for diabetes based on presence and severity of insulin resistance, impaired beta-cell function, and hyperglycemia, then treated accordingly.
Among patients with coronary artery disease, severity and frequency of hypoglycemia were associated with increased levels of high-sensitivity cardiac troponin T, although the association was attenuated in adjusted analyses.
The guideline, developed by the Joint British Diabetes Societies for Inpatient Care, noted that many patients taking insulin will know more about their usual regimen than the medical and nursing staff responsible for their care.
The American Diabetes Association calls for increasing transparency across the entire supply chain, streamlining the approval process for biosimilars, lowering or removing patient cost-sharing, and increasing access to health care coverage for
Preoperative glucose levels may predict postoperative cardiac outcomes regardless of whether patients have diabetes
For patients without diabetes, predictors of myocardial injury after noncardiac surgery included a casual glucose level of more than 6.86 mmol/L (124 mg/dL) and a fasting glucose level of more than 6.41 mmol/L (116 mg/dL).
Patients on the intermittent energy restriction diet ate 500 to 600 kcal/d on two nonconsecutive days each week and followed their usual diet on the other days. They were compared to a group eating 1,200 to 1,500 kcal/d.